Kirkland advised Mercato Partners Traverse Fund on the deal. Paytient announced a $40.5 million Series B funding round, bringing the company’s total funding to $63 million....
You must be a Standard 1 Year member to access this content.
Kirkland & Ellis advised funds affiliated with Cressey & Company LP on the acquisition. Cressey & Company announced the acquisition alongside Health Enterprise Partners of The InterMed...
You must be a Standard 1 Year member to access this content.
Kirkland & Ellis and McMillan advised an affiliate of funds advised by SK Capital Partners on the deal, while Davies Ward Phillips & Vineberg advised Apotex....
You must be a Standard 1 Year member to access this content.
Kirkland & Ellis represented Recipharm in the transaction. Recipharm, a global contract development and manufacturing organisation (CDMO) and a portfolio company of EQT, executed the acquisitions...
You must be a Standard 1 Year member to access this content.
Kirkland & Ellis advised Recipharm on the deal. Recipharm, a global contract development and manufacturing organisation (CDMO) and a portfolio company of EQT, executed the acquisition of...
You must be a Standard 1 Year member to access this content.
Cravath, Swaine & Moore represented IBM in the transaction, while Kirkland & Ellis advised Francisco Partners. IBM and Francisco Partners, a global investment firm that specializes...
You must be a Standard 1 Year member to access this content.
Kirkland & Ellis represented VSCP, while Barack Ferrazzano Kirschbaum & Nagelberg represented Safecor in the transaction. Safecor Health, a provider of unit dose drug packaging services,...
You must be a Standard 1 Year member to access this content.
Mintz, Levin, Cohn, Ferris, Glovsky and Popeo and Conyers advised Hyperfine and Liminal Sciences on the deal, while Kirkland & Ellis counseled HealthCor Catalio Acquisition Corp....
You must be a Standard 1 Year member to access this content.
